![A look at the jets flying high above the Paris Air Show [PHOTOS]](https://breakingdefense.com/wp-content/uploads/sites/3/2025/06/Rafale_02-scaled-e1750268097167.jpg?#)
FDA signs off on Gilead’s landmark long-acting PrEP med, signaling new era in HIV prevention
The FDA signed off on Gilead's twice-yearly HIV pre-exposure prophylaxis injection Yeztugo. With the nod, the drug becomes the longest-acting agent in HIV prevention.
The FDA signed off on Gilead's twice-yearly HIV pre-exposure prophylaxis injection Yeztugo. With the nod, the drug becomes the longest-acting agent in HIV prevention.
